Effectdossier · gearchiveerd kwartaal
SMMT
Summit Therapeutics Inc. · Healthcare · Biotechnology
14Gevolgde houders
0Δ houders
38.14MGehouden aandelen
$811.62MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -11.4% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | +5 | 84.29M | $1.23B | +8 | −2 |
| Q1 2026 | 82 | +1 | 68.40M | $1.29B | +10 | −10 |
| Q4 2025 | 81 | 0 | 72.69M | $1.27B | +1 | — |
| Q3 2025 | 15 | -1 | 45.07M | $931.26M | +1 | −3 |
| Q2 2025 | 14 | 0 | 38.14M | $811.62M | +1 | −1 |
| Q1 2025 | 11 | +1 | 18.29M | $352.78M | +1 | — |
| Q4 2024 | 10 | +1 | 17.85M | $318.58M | +1 | — |
| Q3 2024 | 8 | 0 | 10.94M | $239.67M | +1 | −1 |
| Q2 2024 | 8 | — | 7.47M | $58.27M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 9.23M | — | $196.34M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 9.23M | — | $196.34M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 9.23M | — | $196.34M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Fidelity (FMR) ✦ | 9.23M | — | $196.34M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | The Vanguard Group ✦ (passief) | 8.67M | — | $184.58M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | The Vanguard Group ✦ (passief) | 8.67M | — | $184.58M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | The Vanguard Group ✦ (passief) | 8.67M | — | $184.58M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | The Vanguard Group ✦ (passief) | 8.67M | — | $184.58M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | BlackRock ✦ (passief) | 6.85M | — | $145.70M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | State Street Global Advisors ✦ (passief) | 4.02M | -17.2% | $85.50M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | T. Rowe Price ✦ | 3.91M | -40.5% | $83.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 3.91M | -40.5% | $83.10M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Geode Capital Management ✦ (passief) | 2.93M | -10.7% | $62.47M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 25 | Geode Capital Management ✦ (passief) | 2.93M | -10.7% | $62.47M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 26 | Norges Bank ✦ (passief) | 1.39M | +36.5% | $29.58M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 27 | Millennium Management ✦ | 556.01K | -37.3% | $11.83M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 28 | Marshall Wace ✦ | 271.64K | Nieuw | $5.78M | 0.0% | New | 1 | SEC ↗ |
| 29 | Marshall Wace ✦ | 271.64K | Nieuw | $5.78M | 0.0% | New | 1 | SEC ↗ |
| 30 | D. E. Shaw & Co. ✦ | 137.44K | +361.6% | $2.92M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 31 | D. E. Shaw & Co. ✦ | 137.44K | +361.6% | $2.92M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 102.42K | -89.8% | $2.18M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 102.42K | -89.8% | $2.18M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 34 | Wellington Management ✦ | 39.69K | -2.0% | $844,689 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 35 | Wellington Management ✦ | 39.69K | -2.0% | $844,689 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 36 | Wellington Management ✦ | 39.69K | -2.0% | $844,689 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 37 | Wellington Management ✦ | 39.69K | -2.0% | $844,689 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 38 | AQR Capital Management ✦ | 22.31K | -66.0% | $474,799 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 39 | AQR Capital Management ✦ | 22.31K | -66.0% | $474,799 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 40 | AQR Capital Management ✦ | 22.31K | -66.0% | $474,799 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 41 | Gotham Asset Management ✦ | 15.73K | -0.3% | $334,713 | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $5.78M | 0.0% |
| Marshall Wace | $5.78M | 0.0% |
Verlaten
| Adage Capital Partners | $10.38M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 223 houders, 118.88M aandelen, $2.10B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API